Rating Change
BTIG analysts reiterated a Buy rating on Abbott Laboratories (NYSE:ABT) on July 17, 2026.
reiterateNYSE:ABT
BTIG Reiterates Buy Rating on Abbott Laboratories (ABT)
Rating Change BTIG analysts reiterated a Buy rating on Abbott Laboratories (NYSE:ABT) on July 17, 2026. Market Context Abbott Laboratories operates in the Healthcare sector. The…
Market Context
Abbott Laboratories operates in the Healthcare sector. The stock currently trades at $101.15 with a market capitalization of $202.5B. The stock has declined 29.1% over the past 52 weeks.
Analyst coverage from BTIG provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Abbott Laboratories.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Abbott Laboratories
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 17, 2026 | Wells Fargo | Overweight | N/A |
| Jul 17, 2026 | TD Cowen | Buy | N/A |
| Jul 17, 2026 | RBC Capital | Outperform | N/A |
| Jul 17, 2026 | Evercore ISI Group | Outperform | N/A |
| Jul 17, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ABT Stock Page
Frequently Asked Questions
What does a Buy rating mean for ABT?
A Buy rating from BTIG reflects the analyst's outlook on Abbott Laboratories (NYSE:ABT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ABT forecast page.